| Literature DB >> 29860416 |
Eva M Benito1,2, Nuno Cabanelas1,2, Marta Nuñez-Garcia3, Francisco Alarcón1,2, Rosa M Figueras I Ventura1,2, David Soto-Iglesias1,2, Eduard Guasch1,2,4, Susanna Prat-Gonzalez1,2, Rosario J Perea1,2, Roger Borràs1,2, Constantine Butakoff3, Oscar Camara3, Felipe Bisbal4,5, Elena Arbelo1,2,4, José Maria Tolosana1,2,4, Josep Brugada1,2,4, Antonio Berruezo1,2,4, Lluís Mont1,2,4.
Abstract
Aims: Left atrial (LA) fibrosis can be identified by late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) in patients with atrial fibrillation (AF). However, there is limited information about anatomical fibrosis distribution in the left atrium. The aim is to determine whether there is a preferential spatial distribution of fibrosis in the left atrium in patients with AF. Methods and results: A 3-Tesla LGE-CMR was performed in 113 consecutive patients referred for AF ablation. Images were post-processed and analysed using ADAS-AF software (Galgo Medical), which allows fibrosis identification in 3D colour-coded shells. A regional semiautomatic LA parcellation software was used to divide the atrial wall into 12 segments: 1-4, posterior wall; 5-6, floor; 7, septal wall; 8-11, anterior wall; 12, lateral wall. The presence and amount of fibrosis in each segment was obtained for analysis. After exclusions for artefacts and insufficient image quality, 76 LGE-MRI images (68%) were suitable for fibrosis analysis. Segments 3 and 5, closest to the left inferior pulmonary vein, had significantly higher fibrosis (40.42% ± 23.96 and 25.82% ± 21.24, respectively; P < 0.001), compared with other segments. Segments 8 and 10 in the anterior wall contained the lowest fibrosis (2.54% ± 5.78 and 3.82% ± 11.59, respectively; P < 0.001). Age >60 years was significantly associated with increased LA fibrosis [95% confidence interval (CI) 0.19-8.39, P = 0.04] and persistent AF approached significance (95% CI -0.19% to 7.83%, P = 0.08).Entities:
Mesh:
Substances:
Year: 2018 PMID: 29860416 DOI: 10.1093/europace/euy095
Source DB: PubMed Journal: Europace ISSN: 1099-5129 Impact factor: 5.214